Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-025185
Filing Date
2024-08-07
Accepted
2024-08-07 16:12:45
Documents
91
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q opk20240630_10q.htm   iXBRL 10-Q 2439296
2 EXHIBIT 10.1 ex_708391.htm EX-10.1 871900
3 EXHIBIT 10.2 ex_708392.htm EX-10.2 18350
4 EXHIBIT 31.1 ex_677908.htm EX-31.1 12385
5 EXHIBIT 31.2 ex_677909.htm EX-31.2 12307
6 EXHIBIT 32.1 ex_677910.htm EX-32.1 3887
7 EXHIBIT 32.2 ex_677911.htm EX-32.2 3792
  Complete submission text file 0001437749-24-025185.txt   13198896

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA opk-20240630.xsd EX-101.SCH 88763
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opk-20240630_cal.xml EX-101.CAL 67990
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240630_def.xml EX-101.DEF 723935
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240630_lab.xml EX-101.LAB 573379
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240630_pre.xml EX-101.PRE 760266
94 EXTRACTED XBRL INSTANCE DOCUMENT opk20240630_10q_htm.xml XML 2234047
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 241183898
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)